MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan EP News Bureau Oct 27, 2025 The agreement grants MEDINET rights to develop and commercialise Stempeucel for CLTI indication in Japan, with manufacturing to…
Stempeutics India and Novumcella Japan to work on development co-operation of Stempeucel product for… EP News Bureau Jun 1, 2020 As per the agreement, Novumcella will initially provide regulatory support services to Stempeutics for getting approval from…
